All News Jiangsu Nhwa Pharmaceutical Co., LTD

Equities

002262

CNE100000CG8

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
22.24 ^CNY	-0.36%		-6.40%	-17.99%

Jun. 20	Nhwa Pharmaceutical's Penehyclidine Hydrochloride Injection Passes Regulatory Testing	MT
Jun. 20	Nhwa Pharmaceutical Gets Registration Certificate for Pregabalin Capsules	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nhwa Pharmaceutical's Penehyclidine Hydrochloride Injection Passes Regulatory Testing	Jun. 20	MT
Nhwa Pharmaceutical Gets Registration Certificate for Pregabalin Capsules	Jun. 19	MT
Nhwa Pharma Gets China Nod to Register Epilepsy Drug	May. 24	MT
Jiangsu Nhwa Pharmaceutical Co., Ltd Approves Cash Dividend for 2023, Payable on 15 May 2024	Apr. 24	CI
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets	Apr. 03	MT
Jiangsu Nhwa Pharmaceutical Co., Ltd Proposes Profit Distribution for 2023	Apr. 01	CI
Nhwa Pharmaceutical's 2023 Profit Climbs 15% as Revenue Rises 17%	Apr. 01	MT
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO in China	Feb. 27	AQ
Exchange-Traded Funds Higher, Equity Futures Lower Pre-Bell Monday Ahead of Data-Packed Week	Feb. 26	MT
Teva Pharmaceutical Investments Singapore Pte Ltd. and Jiangsu Nhwa Pharmaceutical Co., LTD Forge Strategic Partnership to Promote Patient Access to Austedo® in China	Feb. 26	CI
Nhwa Pharmaceutical Gets Green Light from US FDA After Addressing API Deficiencies	Dec. 21	MT
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Beijing Yihua M-Health Technology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Jiangsu Nhwa Pharmaceutical Co., LTD	23-10-24	CI
Jiangsu Nhwa Pharmaceutical Co., LTD(XSEC:002262) added to FTSE All-World Index	23-09-18	CI
Jiangsu Nhwa Pharma’s H1 Profit Jumps 21.7% as Revenue Rises 20%	23-07-31	MT
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-30	CI
Wang Zeyu cancelled the acquisition of 13% stake in Jiangsu Farever Pharma Co., Ltd. from Jiangsu Nhwa Pharmaceutical Co., LTD.	23-07-27	CI
Expected House Vote on Debt Ceiling Deal Weighs on Sentiment, Pushing US Equity Futures Lower	23-05-31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Jiangsu Nhwa Pharmaceutical Co., LTD

Equities

002262

CNE100000CG8

All News

Filters